It’s no secret that patients struggle with taking their medication. Whether they forget or purposely avoid taking it, a patient’s outcome could be affected. If a patient is in a clinical trial and isn’t following protocol by taking their medication as instructed, it ruins the legitimacy of the trial’s data and ultimately puts other lives […]
Posts Tagged ‘biotech’
Digital Transformation Is Inevitable, But Where Do We Begin?
Most digital transformation initiatives begin with customer journey mapping, a process that helps fully understand the dynamics of your target customer and their behavior. Journey mapping connects the dots from your customer’s initial interaction with your brand, through their entire experience with your brand via multiple channels (e.g., website, mobile app, phone call, direct […]
Using Technology For Risk Management In Clinical Trials
Risk-based monitoring (RBM) continues to be a hot topic among sponsors and contract research organizations (CROs) for a variety of reasons, including the time- and cost-savings it can offer, as well as its ability to help keep patients safe. Last week, Ashok Ghone, Ph.D., vice president of global services at MakroCare USA, wrote a […]
Why Digital Transformation Matters In Life Sciences
In today’s digital age, consumers have evolved to become far more independent and self-sufficient. They now expect access to information, services, and products to be quick, easy, useful, engaging, and even entertaining. Businesses that are not yet meeting these new expectations are falling behind the curve.
3 BI And Analytics Trends That Are Hard To Deny
According to IBM, we generate 2.5 quintillion bytes of data every day. And, 90% of the data that exists today, whether found in your clinical systems, on social media, or on your mobile devices, has been gathered within the last two years. All of that is what we call “big data.” As the volume […]
How One Pharma Is Leveraging Social Communities
In the good ol’ days, walking in the clinic door and asking for a few minutes of a physician’s time was the main method used by sales reps to position a drug in the doctor’s mind. Physician outreach was, and still is, one of the most effective ways to penetrate the market with a […]
The Final Frontier: Paper-Based Validation Testing
As a big fan of efficiency, it pains me that most of us in life sciences still execute validation testing with pen and paper, present company included. All of those poor trees. All of that hand-cramping. All of that scanning. All of those migraine-inducing QA reviews in which we’re squeezing scanned test cases into […]
Why Life Sciences Needs A Lesson From Southwest Airlines
The life sciences industry could learn a little something from Southwest Airlines’ “Transfarency” campaign, in terms of reporting clinical trial results. A recent investigation by the publication STAT found significant violations in the reporting of clinical trial results to the ClinicalTrials.gov database. Most academic research institutions, drug companies, and even the National Institutes of […]
FDA Warning Letter For Shared Passwords (And Other Offenses)
On December 17, 2015, the FDA issued a warning letter to Sun Pharmaceuticals Industries Ltd. in Gujarat, India. Sun Pharma’s website boasts that it is the “World’s 5th Largest Specialty Generic Pharmaceutical Company” with over 2,000 products in more than 150 markets across the globe. When an organization that large winds up with a […]
Good Chance Your Doctor Doesn’t Know Your Med’s Real Indication
This is bizarre. It turns out that many doctors don’t know what the real, FDA-approved indications are for the medications they’re prescribing. In a Wall Street Journal article that discusses the risks of off-label uses for prescription drugs, the author cites a 2009 study of 1,199 physicians (mostly primary care doctors and psychiatrists) that […]
A Lesson In Drug Pricing
Presidential debates. Daraprim. Martin Shkreli. Drug pricing is what everyone’s talking about. Dr. Joshua P. Cohen, a research associate professor at the Tufts Center for the Study of Drug Development, wrote an excellent article that breaks down how drug prices are determined. He also shared some key facts that support the notion of the […]
Why And How Are Companies Investing In Precision Medicine
HIT Consultant, a digital publication focused on healthcare technology, recently shared a report by Reed Smith on mergers and acquisitions (M&A) in life sciences and how personalized medicine is playing an important role in many of today’s transactions. While pharmaceutical and biotechnology companies have not abandoned the “one-size-fits all” approach to developing drugs, many […]